355-37-3

应用筛选条件

关键词:'355-37-3'

显示 1-6 共 6 条结果关于 "355-37-3" 范围论文

Molecular cloning and characterization of human WNT3.

M Katoh

International journal of oncology, 19(5), 977-982 (2001-10-18)

Mouse Wnt-3 is a proto-oncogene, which is activated by mouse mammary tumor virus (MMTV). Human WNT3 cDNA fragment, previously isolated by another group, corresponds to a partial coding sequence. WNT3 cDNA, spanning the complete coding sequence, was isolated in this

Synthesis and characterization of improved chloride-sensitive fluorescent indicators for biological applications.

A S Verkman et al.

Analytical biochemistry, 178(2), 355-361 (1989-05-01)

A class of N-substituted quinoline compounds has been introduced recently for the fluorescence measurement of Cl concentration in biological preparations. The most Cl-sensitive compound was 6-methoxy-N-[3-sulfopropyl] quinolinium with peak excitation and emission wavelengths of 350 and 442 nm and a

Randomized phase III trial to test accelerated versus standard fractionation in combination with concurrent cisplatin for head and neck carcinomas in the Radiation Therapy Oncology Group 0129 trial: long-term report of efficacy and toxicity.

Phuc Felix Nguyen-Tan et al.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 32(34), 3858-3866 (2014-11-05)

We tested the efficacy and toxicity of cisplatin plus accelerated fractionation with a concomitant boost (AFX-C) versus standard fractionation (SFX) in locally advanced head and neck carcinoma (LA-HNC). Patients had stage III to IV carcinoma of the oral cavity, oropharynx

Axitinib versus sorafenib as second-line treatment for advanced renal cell carcinoma: overall survival analysis and updated results from a randomised phase 3 trial.

Robert J Motzer et al.

The Lancet. Oncology, 14(6), 552-562 (2013-04-20)

In a phase 3 trial comparing the efficacy and safety of axitinib versus sorafenib as second-line treatment for metastatic renal cell carcinoma, patients given axitinib had a longer progression-free survival (PFS). Here, we report overall survival and updated efficacy, quality

Inositol in preterm infants at risk for or having respiratory distress syndrome.

Alexandra Howlett et al.

The Cochrane database of systematic reviews, 7, CD000366-CD000366 (2019-07-10)

Inositol is an essential nutrient required by human cells in culture for growth and survival. Inositol promotes maturation of several components of surfactant and may play a critical role in fetal and early neonatal life. A drop in inositol levels

Design of oxytocin antagonists, which are more selective than atosiban.

M Manning et al.

Journal of peptide science : an official publication of the European Peptide Society, 7(9), 449-465 (2001-10-06)

We report the solid phase synthesis of four pairs of L- and D-thienylalanine (Thi/D-Thi) position two modified analogues of the following four oxytocin (OT) antagonists: des-9-glycinamide [1-(beta-mercapto-beta,beta-pentamethylene propionic acid), 2-O-methyltyrosine, 4-threonine]ornithine-vasotocin (desGly(NH2)9,d (CH2)5[Tyr(Me)2,Thr4]OVT) (A); the Tyr-(NH2)9 analogue of (A), d(CH2)5[Tyr(Me)2,Thr4,Tyr-(NH2)9]OVT

1/1